Peripheral IV Catheters Market Outlook 2024: Exclusive Report By The Business Research Company | Becton, Dickinson and Company, B. Braun Melsungen AG, Smiths Medical Inc., Vygon SAS, Terumo Corporation, Teleflex Incorporated, NIPRO Medical Corporation

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2615

The Business Research Company offers in-depth market insights through Peripheral IV Catheters Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The peripheral iv catheters market size has grown strongly in recent years. It will grow from $5.19 billion in 2023 to $5.58 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to growing healthcare facilities, aging population and chronic diseases, surgical and medical procedures, increased hospital admissions, demand for vascular access devices.

The peripheral iv catheters market size is expected to see strong growth in the next few years. It will grow to $7.67 billion in 2028 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to minimally invasive procedures and catheters, short peripheral catheters for outpatient care, catheter-related bloodstream infection prevention, expansion of home healthcare, integration of antimicrobial coatings.. Major trends in the forecast period include ultrasound-guided peripheral iv catheter insertion, reduced complications and catheter failure, wireless communication for catheter monitoring, patient-centered catheter care, shift toward disposable catheters.

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=6658&type=smp

Market Segmentation:
The main types of peripheral IV catheters are short peripheral intravenous catheters and integrated/closed peripheral intravenous catheters (PIVC). A short peripheral catheter is less than 3 inches long. The technology used in peripheral IV catheters is conventional peripheral intravenous catheters, a safety PIVC that is used across various end-users such as hospitals, clinics, ambulatory surgical centers, and home healthcare.

Major Driver - Growing Prevalence Of Chronic Diseases Drives Expansion Of The Peripheral Iv Catheters Market
The rising prevalence of chronic diseases is expected to propel the growth of the peripheral IV catheters market. Peripheral intravenous catheters are commonly used in the management of various chronic diseases such as cancer, cardiovascular diseases, and others. For instance, in March 2022, according to the Australian Bureau of Statistics, an Australia-based self-governing statutory entity in charge of gathering and analyzing information as well as factual proposals, almost half of the population (46.6%, or 11.6 million) had a minimum of one chronic illness. The most common chronic conditions were mental and behavioral problems (20.1%), back pain (15.7%), and arthritis (12.5%). Therefore, the rising prevalence of chronic diseases is expected to propel the growth of the peripheral IV catheters market.

Competitive Landscape:
Major companies operating in the peripheral iv catheters market include Becton, Dickinson and Company, B. Braun Melsungen AG, Smiths Medical Inc., Vygon SAS, Terumo Corporation, Teleflex Incorporated, NIPRO Medical Corporation, Argon Medical Devices Inc., Medical Components Inc., Vascular Pathways Inc., Tangent Medical Technologies Inc., Vigmed AB, Venner Medical, C. R. Bard Inc., MedSource Labs, Intra Special Catheters GmbH, Greiner Bio-One International GmbH, Ares Medikal, Ace Medical Company, Heka s.r.l, Raumedic AG, Vogt Medical Vertrieb GmbH, RenovoRx Inc., Retractable Technologies Inc., AngioDynamics Inc., ICU Medical Inc., Medtronic plc, Edwards Lifesciences Corporation, Cook Group Incorporated, Stryker Corporation, Boston Scientific Corporation, Johnson & Johnson, Abbott Laboratories, Merit Medical Systems Inc.

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/peripheral-iv-catheters-global-market-report

Top Trend - Technological Advancements Reshaping The Peripheral Iv Catheters Market Enhanced Safety And Efficiency
Technological advancements are shaping the peripheral IV catheters market. Many companies in the market are developing new products to provide technically enhanced products to their users. B. Braun Medical, a US-based infusion therapy company, launched the new Introcan Safety 2 IV cathetar with one-time blood control. The new product makes the IV access safer for clinicians by reducing the risk of needlestick injuries.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Peripheral IV Catheters Market Characteristics
3. Peripheral IV Catheters Market Trends And Strategies
4. Peripheral IV Catheters Market - Macro Economic Scenario
5. Peripheral IV Catheters Market Size And Growth
…..
27. Peripheral IV Catheters Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.